Our pipeline of therapies targeting unmet needs in oncology
etiraRx Programs
Our novel molecular platform is driving the development of first-in-class targeted therapies treating a broad range of tumors.
Targeted Oncology
Cancer
Drug
Metastatic Breast Cancer
ERX-315
ERX-41
Ovarian Cancer
ERX-208
Pancreatic Cancer
ERX-358
Glioblastoma
ERX-342